BALAXI.NS · BALAXI PHARMACEUTICALS LIMITED
India · RS rating 28 · As of 2026-10-14
| Price | 22.18 INR |
|---|---|
| 1-day change | -0.1% |
| RS rating (overall / 1M / 3M / 12M) | 28 / 41 / 44 / 8 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 32 / 24 / 24 |
| Industry group (rank) | Medical-Generic Drugs (93) |
| EPS growth Q/Q | +118.2% |
| Sales growth Q/Q | +14.1% |
| Distance from 52-week high | +49.2% |
| Market cap (USD) | $13.0M |